Cardiovascular Complications of COVID-19 : Acute and Long-Term Impacts (Contemporary Cardiology)

個数：

Cardiovascular Complications of COVID-19 : Acute and Long-Term Impacts (Contemporary Cardiology)

Banach, Maciej (EDT)

ウェブストア価格 ¥35,422（本体¥32,202）
Humana（2023/12発売）
外貨定価 US$ 169.99
ポイント 322pt

在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
通常6～9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合がございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Paperback:紙装版/ペーパーバック版／ページ数 437 p.
言語 ENG
商品コード 9783031154805

Full Description

This book is the first comprehensive approach on COVID-19 cardiac complications, both during the acute phase as well as in the long-COVID period. It provides an up-to-date and highly illustrated summary of the biology of SARS-CoV-2, the course of COVID-19, risk factors that worsen the disease in COVID-19 patients, clinical features of COVID-19 patients, COVID-19 cardiological complications, treatment, and prevention methods, and long-term cardiological aspects of COVID-19.
Chapters provide the reader with a contemporary perspective on the emerging links between COVID-19 and cardiovascular disease. In addition, this volume discusses the clinical implications and therapeutic goals in patients with COVID-19 and cardiac complications, as well as possible therapeutic options. It also offers clear recommendations on how to manage (both non- and pharmacologically) to avoid the increased number of COVID-19 related deaths due to CVD and its risk factors.

Cardiovascular Complications of COVID-19 will be the primary resource for physicians, residents, fellows, and nursed and medical students in the fields of cardiology and COVID-19/infectious diseases as well as healthcare providers that initiate preventive activities and dedicated programs.

Part I: Introduction.- Biology of SARS-CoV-2 coronavirus; origin, structure, and variants.- Epidemiology of COVID-19.- Clinical symptoms and course of COVID-19.- Risk factors of developing COVID-19 and its severe course.- Prognosis in COVID-19 patients - statistics, risk factors.- Part II: Cardiovascular Implications of the Acute Phase of COVID-19.- Myocardial injury in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment).- Acute coronary syndrome - destabilization of atherosclerotic plaque in COVID-19 (epidemiology, influence on prognosis, pathogen-esis and treatment).- Acute Vascular Injury in COVID-19.- Heart failure and acute circulatory failure in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) .- Cardiomyopathy in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment).- Arrhythmias in COVID-19.- Thromboembolic events in COVID-19 .- Stroke in COVID-19.- Pulmonary embolism after COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment).- Interaction of anti-COVID-19 drugs with cardiovascular therapy.- Part III: Influence of the Treatment of Cardiovascular Diseases on the Course of COVID-19.- Beyond the vaccines-Bioactive lipids in COVID-19.- Statins and COVID-19 (mechanism of action, effect on prognosis).- Covid-19 And Antihypertensive Treatment.- Colchicine in COVID-19 (mechanism of action, effect on prognosis).- Antiplatelet drugs in COVID-19: mechanism of action and effect on prognosis.- Antidiabetic drugs in COVID-19.- Part IV: Cardiovascular Complications of Long-COVID-19.- Long COVID-19 - Definition, Epidemiology, and Clinical Implications.- Cardiovascular complications of long COVID-19 - prevalence, diagnosis and risk factors.- Cardiovascular complications of Long-COVID - management.- Part V The impact of COVID-19 pandemic on the e-services and digital tools development in medicine.- The impact of the COVID-19 pandemic on e-services and digital tools development in medicine.